Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer

2 vistas
administrator
administrator
09/30/23

Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.

  • categoría

Mostrar más

0 Comentarios Ordenar por

No se encontraron comentarios

Comentarios de Facebook

Hasta la próxima